跳至主要内容
临床试验/NCT06260982
NCT06260982招募中不适用

Cognitive Disorders and Metabolism in 18-FDG- PET in Hereditary Spastic Paraplegia Type 4 (SPG4)

Central Hospital, Nancy, France1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
cognitive testing

研究概览

简要总结

Hereditary spastic paraplegia type 4 is the most frequent mutation of hereditary spastic paraplegias. It is commonly described as pure, with progressive weakness of the lower limbs, pyramidal syndrome and vesico-sphincter disorders. However, cognitive disorders have been reported for over 20 years, but remain poorly characterized.

详细描述

Our primary objective is to describe a pattern of cognitive impairment in Hereditary Spastic Paraplegia type 4 using 18-FDG-PET metabolic imaging.

As secondary objectives, we wish to study the presence of correlations between neuropsychological tests, clinical examination, 18-FDG-PET data and general and genetic data of the pathology. We also wish to investigate correlations between genotype and phenotype.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient over 18 years of age, living in the Grand Est region (France)
  • Patient with a pathogenic or probably pathogenic variant (class 4 or 5) in the SPAST gene.

排除标准

  • dementia comorbidities or cognitive disorders unrelated to the pathology that may affect neuropsychological tests.

结局指标

主要结局

cognitive testing

时间窗: baseline

we use detailed neuropsychological tests (MoCA)

次要结局

  • Correlations between neuropsychological tests, clinical examination, PET and general data.(baseline)
  • Genotype/Phenotype correlations(baseline)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Principal Investigator
主要研究者

RENAUD Mathilde

Principal investigator

Central Hospital, Nancy, France

研究点 (1)

Loading locations...

相似试验